CLOs on the Move

Dental Technologies

www.dentaltechno.com

 
Dental Technologies, Inc is a company specializing in the research, formulation, compounding and packaging of dental, orthodontic and oral pharmaceutical products.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Medshare

Medshare is a Guelph, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Midwestern Connecticut Council on Alcoholism (MCCA)

Midwestern Connecticut Council on Alcoholism (MCCA) is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Midwestern Connecticut Council on Alcoholism (MCCA) is based in Danbury, CT. You can find more information on Midwestern Connecticut Council on Alcoholism (MCCA) at www.mccaonline.com

Beacon Behavioral Health - Baton Rouge

Beacon Behavioral Health - Baton Rouge is a Baton Rouge, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

UT Medical Group

UT Medical Group is the private practice arm of the University of Tennessee Health Science Center (UTHSC) faculty. Because the physicians in our group are actively involved in teaching and research, they remain current with the latest medical developments. As a not-for-profit, non-tax-supported group practice, UT Medical Group is dedicated to quality patient care, medical education, and medical research. This allows us to offer many unique, advanced health care services to people in the Mid-South at competitive prices. Ties to UTHSC allow the physicians at UT Medical Group access to the latest treatments, special protocols and labs, as well as a broad spectrum of professionals with advanced degrees in nursing, nutrition, pharmacology, psychology, and more. This involvement benefits not only our patients' treatments, but keeps the physicians at the top of their fields.  

Histogenics

Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Histogenics` regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Histogenics` first investigational product candidate, NeoCart®, leverages its platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.